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A B S T R A C T  
 
Single nucleotide polymorphisms (SNPs), ACE rs4341 and NOS3 rs1799983 have been reported to 
be associated with coronary artery disease (CAD) and blood pressure (BP)in many but not all 
studies. We aimed to investigate the effect of these SNPs on BP and CAD in people from Punjab, 
Pakistan. A total of 650 subjects (430 CAD cases and 220 controls) were genotyped by 
TaqMan/KASPar allelic discrimination technique. Two BP measurements were reordered and their 
mean was calculated. The results showed that the risk allele frequencies (RAFs) of both SNPs were 
higher in cases than controls but the difference was not statistically significant. For rs4341, RAF in 
cases and controls was 0.577 vs. 0.525, p = 0.08 and for rs1799983, the RAF was 0.202 vs. 0.178, p 
= 0.31. The SNPs were not associated with CAD. The CAD odds ratio of rs4341 (1.22,0.97-1.53, p = 
0.09) and that of rs1799983 (1.15, 0.86-1.54, p=0.33) was not statistically significant. Mean systolic 
blood pressure (SBP) and diastolic blood pressure (DBP) were significantly higher in cases than 
controls (p<0.05) and the SNPs showed a significant association with BP. Each risk allele of rs4341 
(G) increased SBP by 10.04±0.8 mmHg and DBP by 2.5±0.6mmHg, while risk allele of rs1799983 
(T), increased SBP and DBP by 16.4±0.9mmHg and 8.8±0.6mmHg respectively, all were 
statistically significant (p<0.05). When a combined effect of genotypes of both SNPs was examined, 
a significant effect on CAD outcome (p=0.01) was observed when GG of rs4341 and GT of 
rs1799983 co-existed. Similarly, maximum elevation in BP was observed when risk alleles of both 
SNPs in homozygous form (GG and TT) appeared together. In conclusion, the SNPs were not 
independently associated with CAD but were associated with BP in Pakistani subjects under study 
and may be causing CAD by modulating BP. 
 
 
INTRODUCTION 
 
 Coronary artery disease (CAD) remains the 
leading cause of death worldwide and Pakistan is among 
the highest risk countries. Both environmental and 
genetic factors have role in development of CAD and 
hypertension is an independent CAD risk factor. 
Hypertension (HTN) is caused by behavioural factors like 
increased saturated fat and dietary sodium intake, 
physical inactivity, mental stress as well as genetic 
factors (Perry et al., 1994; Williams et al., 1994; Freitas 
et al., 2007). The heritability of HTN has been estimated 
to be about 30% and its genetic nature is polygenic 
involving multiple genes (Lifton, 1996; Morris and 
Griffiths, 1998; Rice et al., 2000). Mutations or common 
variants in the genes regulating BP and vascular 
homeostasis may have a role in predisposition to HTN 
(Dickson and Sigmund, 2006; Butler, 2009). Pakistan is 
emerging as an epicentre of the global HTN epidemic. A  
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survey conducted by the Pakistan Medical Research 
Council showed that 16.2% of the rural and 21.6% the 
urban Pakistani population is hypertensive 
(www.heartfile.org/pdf/surveillance). Keeping in view 
that the prevalence of HTN and CAD in Pakistan is 
different than that of western countries from where most 
of the studies have been reported,we examined the 
association of two SNPs, ACE rs4341 and NOS3 
rs1799983 with BP and CAD in a small group of 
Pakistani people. 
 The NOS3 gene consists of 26 exons and gives rise 
to a 1203 amino acids long protein (Miyahara et al., 
1994; Nadaud et al., 1994). The NOS3 is second most 
reported gene for association with CAD and fourth most 
important for association with myocardial infarction (MI) 
(www.hugenavigator.net). Hingorani et al. (1995) first 
described a point mutation in this gene at nucleotide 
1917. The polymorphism rs1799983 (Glu298Asp or 
E298D) is a G>T missense variation located in the exon 7 
of the gene (Hingorani et al., 1995). The substitution of 
the codon GAG to GAT in the 894 position (G894T), 
changes glutamate with aspartate (Glu298Asp) in the 
protein. A possible cause of reduction in NOS activity 
due to this polymorphism is that the 894Asp substitution 
Article Information 
Received 13 November 2015 
Revised 29January 2016 
Accepted 14 March  2016 
Available online 1 June 2016 
 
Authors’ Contribution 
SUS performed experiments, 
analysed the data and wrote the 
manuscript. S helped in performing 
experiments and assisted in writing 
manuscript. JAC helped in statistical 
analysis. AR and SEH designed and 
supervised the study. 
 
Key words 
Coronary artery disease, Blood 
pressure, TaqMan, KASPar. 
S. U. SHAHID ET AL. 1126
might cause an increase in the susceptibility of the 
protein for degradation due to a tight run of alpha helix 
(Kelm, 2006). This amino acid change may also affect 
protein-protein interaction and interaction of the protein 
with chaperon (Monti et al., 2003). The protein variant 
with this change has different susceptibility to cleavage, 
that is an amino terminal 35kDa and carboxy terminal 
100 kDa fragments (Tesauro et al., 2000). A meta-
analyses of 42 published studies comprising 13876 cases 
and 13042 controls revealed significant association of 
this polymorphism with CAD (OR 1.17, C.I 1.07-1.28, 
p=0.001) (Casas et al., 2006a). Similarly, the SNP was 
significantly associated with MI in Asians (Luo et al., 
2014). In a recent large meta-analysis, including 132 
studies from all over the world, the polymorphism was 
associated with CAD (OR range 1.28-1.52, p<0.00001) 
(Rai et al., 2014). This polymorphism was also associated 
with essential hypertension in two independent Japanese 
populations and the allele frequency of 298Asp was 
significantly high in hypertensive than normotensive 
subjects (Miyamoto et al., 1998). 
 The renin angiotensin system (RAS) maintains body 
fluid levels and cardiovascular functioning (Abdollahi et 
al., 2008). The angiotensin converting enzyme (ACE) is a 
major player of this system and converts angiotensin I to 
angiotensin II and inactivates bradykinin which is a 
vasodilator. Strong genetic control of ACE regulation has 
been reported (Cambien et al., 1988). The ACE gene is 
21 kb in length consisting of 26 exons and 25 introns. 
Most of the common variants reported in this gene to date 
are in the noncoding region (Sayed-Tabatabaei et al., 
2006). The gene contains an important polymorphism 
consisting of an ALU repeat of 287 base pairs in intron 
16. The polymorphism is characterized by either an 
insertion (I) or deletion (D) of the repeat (Eisenmann et 
al., 2009). The DD genotype is associated with higher 
levels of the enzyme as compared to the II and ID 
genotype (Rigat et al., 1990). The D allele of the SNP 
was found to be significantly associated (p=0.0005, OR 
4.157) with hypertension in a study on Indian people 
(Choudhury et al., 2012). In a meta-analysis of 46 studies 
comprising of 32715 white individuals, the ID and DD 
allele conferred greater susceptibility (p<0.001) to 
ischemic disease than II allele (Agerholm-Larsen et al., 
2000). Since the I/D polymorphism is in the non-coding/ 
intronic region, it is less likely to be a functional variant 
(Rigat et al., 1990). The polymorphism ACE rs4341 is in 
complete linkage disequilibrium (LD) with the I/D 
polymorphism of this gene and can be a best proxy for 
I/D polymorphism (Domingues-Montanari et al., 2010). 
 Both of these SNPs were identified in candidate 
gene studies predating genome wide association study 
(GWAS), however, these SNPs have now been studied in 
GWAS but were not found to be associated with CAD in 
GWAS (Casas et al., 2006). The reasons may be false 
associations in candidate gene studies, publication bias or 
the effect of the SNPs may be too small to reach GWAS 
significance threshold. The objective of the current study 
was to examine whether the common variants in the 
above mentioned genes having potential role in 
regulation of vascular physiology and RAS system are 
associated with HTN and CAD in Pakistani people. 
 
MATERIALS AND METHODS 
 
Study subjects 
 The study consisted of 430 CAD cases and 220 
controls. The CAD cases were reported as ischemic heart 
disease patients based upon ECG, cardiac echo, 
radiological and biochemical markers of cardiac ischemia 
(CK-MB and troponinT/I levels). All cases were newly 
diagnosed and were not taking any lipid lowering or anti-
hypertensive drugs. Controls were age, sex and ethnicity 
matched individuals without any history of 
cardiovascular disease. The exclusion criteria included 
the presence of chronic diseases like cancer, kidney or 
liver disease and any on-going acute infection. All the 
procedures were in compliance with the Helsinki 
declaration. The case history and other details were 
collected after obtaining an informed written consent. 
The study was approved by the institutional ethical 
committee, University of the Punjab, Lahore. 
 
Genotyping 
 Genomic DNA was extracted from whole blood 
leucocytes using Promega Wizard® Genomic DNA 
purification kit. DNA was quantified using nanodrop 
(ND-8000, USA). The DNA samples were diluted to a 
fixed concentration (1.25ng/µl). A 4µl of this dilution 
was used to get a final working concentration of 5ng of 
DNA. The DNA arraying into 384 well plates was done 
by a liquid handling robotic system (Biomerk FX, 
Beckman Coulter). Specially designed plates (Micro 
Amp) suitable for fluorescence amplification were used. 
The NOS3 rs1799983 was genotyped by TaqMan allelic 
discrimination technique. The TaqMan reaction mixture 
consisted of 1X KAPA qPCR master mix 
(KAPABiosystems, USA), 100nM of each primer, 
100nM of each probe, ROX high (0.4µl/20µl reaction 
mixture), 5ng DNA and PCR grade water as needed. The 
PCR program consisted of an initial temperature of 50°C 
for 2 min, denaturation/enzyme activation at 95°C for 10 
min followed by amplification for 40 cycles each 
consisting of denaturation at 95°C for 15 sec and 
amplification at 60°C for 1 min. The programme was run 
on BioRad C1000TM thermal cycler. 
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Table I.- Sequence of primers and probes used for rs1799983 assay. 
 
SNP 40x Primer and probe Sequence of primers and probes 
    
rs1799983 NOS3_G894T_F Primers GGCTGGACCCCAGGAAA 
NOS3_G894T_R Primers CACCCAGTCAATCCCTTTGGT 
NOS3_G894T_VIC Probe VIC =T CCCAGATGATCCCCCA 
NOS3_G894T_FAM Probe FAM=G CCAGATGAGCCCCCA 
    
 
Table II.- Sequence of primers used for rs4341 assay. 
 
SNP Sequence, 50bp either side of the polymorphism [C/G]. FAM VIC 
    
rs4341 TCTCTGAGCTCCCCTTACAAGCAGARGTGAGCTAAGGGCTGGARCTYAAG[C/G]CATT
CMAMCCCCTACCAGATSTGACGAATRTGATGGCCRCRTCCCGGAAA 
C G 
    
 
 The ACE rs4341 was genotyped by KASPar 
(KBiosciences Competitive Allele Specific PCR) 
technique. The assay mixture per plate consisted of 950µl 
of each of KASPar master mix and Sigma water and 
26.4µl of SNP assay (consisting of allele specific primers 
and labelled probes). The touchdown thermal cycler 
program consisted of an initial denaturation/enzyme 
activation at 94°C for 15 min, then 10 cycles comprising 
of 94°C for 20 sec and annealing/extension temperature 
reducing from 65°C to 57°C lowering 0.8°C per cycle. 
The final round consisted of 26 cycles each consisting of 
94°C for 20 sec and annealing/extension at 57°C for 60 
sec. The information about the primers and probes used 
in TaqMan and KASPar genotyping is available in Tables 
I, II.  
 After amplification, the results were analysed on 
ABI Prism 7900HT (Applied Biosystems/Life 
Technologies) and the genotypes were called using 
sequence detection software (SDS) version 2.0. The 
genotypes were also confirmed randomly by conventional 
direct DNA sequencing (source biosciences, UK) to 
check the accuracy of techniques and the results were 
always concordant. 
 
Statistical analysis 
 Statistical analyses were performed using the 
Statistical Package for Social Sciences (SPSS version 22, 
IBM statistics). The student t-test was used to compare 
continuous variables between case and control groups. 
The normality of outcome variable (blood pressure) was 
checked by drawing normal distribution curve. The 
studied population was checked for Hardy Weinberg 
equilibrium (HWE) by a Chi-square goodness of fit test. 
Allele and genotype frequencies were calculated by an 
excel spread sheet (Johnson, 1975) and also confirmed by 
direct counting. Allele frequencies were compared 
between cases and controls using chi-squared test. As 
CAD is a binary variable, the association of genotypes 
with CAD (OR) were obtained by binary logistic 
regression taking “CAD status” as dependent variable 
and the “genotypes” as covariate. Similarly, the 
association of blood pressure with CAD was also 
examined using binary logistic regression. The mean 
blood pressure levels across different genotypes were 
calculated by one way analysis of variance (ANOVA) 
taking blood pressure as the dependent variable and 
genotype as the factor. The effect sizes of the SNPs on 
blood pressure (β effect/β coefficients), which is the 
increase in blood pressure for each additional risk allele 
held were obtained by linear regression taking blood 
pressure as dependent variable and genotype as 
independent variable. 
 The power of the sample size used in study was 
calculated using an online calculator 
(https://www.dssresearch.com/KnowledgeCenter/toolkitc
alculators/statisticalpowercalculators.aspx). A p-value 
<0.05 was considered significance cut-off for all 
measurements. 
 
RESULTS 
 
 The general characteristics of the cases and controls 
are shown in Table III. As expected, cases had higher 
percentage of hypertension and diabetes than controls and 
smoking rate was also higher in cases than controls. The 
SBP and DBP were normally distributed and significantly 
different among cases and controls. The cases had higher 
blood pressure values as compared to the controls. Both 
systolic and diastolic blood pressures were significantly 
associated with CAD status as shown by their OR  
(Table IV). 
 Both SNPs showed good genotyping results call 
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rates (~98%) and for both SNPs the population examined 
was in Hardy Weinberg equilibrium (Table VI). For the 
SNP ACE rs4341, the common allele G is the risk allele 
and the risk allele frequency (RAF) was higher in cases 
than controls but the difference was not significant 
statistically (0.57 vs. 0.525, p = 0.079). For NOS3 
rs1799983, the minor allele T is the risk allele which was 
non-significantly (0.202 vs. 0.178, p = 0.332) higher in 
cases than controls (Table VI). Although the cases had 
higher number of risk allele for both SNPs but the 
association with CAD was not significant in the studied 
samples in either of additive, dominant and recessive 
models examined. The per allele CAD odds ratio (OR) of 
both the SNPs was not statistically significant (Table VI).  
 
Table III.- Basic characteristics of the subjects under 
study. 
 
Variables Cases Controls p-value 
    
Sample No. 430 220  
Age (years) 59.1±12.6 56±10.5 0.002 
Sex 
Males (n) 
Females (n) 
 
230 
200 
 
120 
100 
 
0.27 
Diabetes (%) 64.6 13.6 5.1x10-34 
Hypertension 
(%) 
62.1 16.4 8.9x10-28 
Smoking (%) 29.5 10.5 7.3x10-08 
    
Continuous variables are expressed as Mean±SD. Categorical 
variables are expressed as (%). 
 
Table IV.- Blood pressure levels in cases and controls and 
association with CAD. 
 
 Systolic (mmHg) Diastolic (mmHg) 
   
Cases 139.9±16.1 88.0±9.6 
Controls 128.7±14.8 85.3±11.3 
P-value <0.001 0.002 
CAD OR* 1.05 (1.04-1.06) 1.03 (1.01-1.05) 
P-value <0.001 0.002 
   
*Odds ratio for 1 SD increase in blood pressure. 
 
 The presence of risk alleles of both SNPs increased 
SBP and DBP quantitatively. For rs4341, each ‘G’ allele 
increased SBP and DBP by 10.04±0.8 and 2.5±0.6 
mmHg respectively. While rs1799983, per risk allele 
elevation in SBP and DBP was 16.4±0.9 and 8.8±0.6 
mmHg, respectively (Table VII). 
 In order to examine the combined effect of both 
SNPs on CAD, the effect of the combined genotypes was 
examined where common homozygous genotype of 
rs4341 was examined against common homozygous, 
heterozygous and risk homozygous genotypes of 
rs1799983. The association of these genotypic 
combination was significant when risk homozygous of 
rs4341 (GG) and heterozygous of rs1799983 (GT) co-
existed (Table VIII). Similarly, mean SBP and DBP 
increased by the addition of risk alleles of both SNPs and 
maximum elevation was observed when both risk 
homozygous genotypes (GG and TT) existed 
simultaneously (Table IX).  
 
DISCUSSION 
 
 Hypertension, a potential CAD risk factor has 
strong genetic basis. We have studied two SNPs in the 
ACE and NOS3 genes to examine their association with 
HTN and CAD in Pakistani population. Our results 
showed that the ACE rs4341 was associated with 
elevation in blood pressure. This is consistent with two 
other studies where this variant was found to be 
associated with HTN in Pakistani and Indian people 
(Sameer et al., 2010; Choudhury et al., 2012). However, 
in contrast to our findings, in another study carried out on 
Indian people, this polymorphism was not associated with 
HTN (Gupta et al., 2009). The polymorphism was not 
associated with CAD in our study, which is consistent 
with another study conducted by Iqbal et al. (2004). 
Whereas, this polymorphism was found to be associated 
with CAD in a study by Masud and Qureshi (2011) on 
Pakistani people. In a large meta-analysis carried on 
white Caucasians, the ACE polymorphisms were found to 
be associated with ACE levels and CAD but not with the 
HTN (Agerholm-Larsen et al., 2000). Whereas, another 
study reported a modest association of the ACE 
polymorphisms with CAD emphasizing the need of 
bigger study groups with inclusion of more SNPs 
(Samani et al., 1996; Keavney et al., 2000). According to 
Sayed-Tabatabaei et al. (2003) the association between 
risk alleles of the gene and atherosclerosis was stronger 
in the high risk individuals (having other risk factors like 
diabetes and hypertension) than in low risk individuals. 
 The risk allele of NOS3 rs 1799983 SNP was found 
to be significantly associated with elevation in BP in the 
current study. However, in another study in China, the 
risk allele was not found to be associated with essential 
hypertension in northern Han Chinese but a subsequent 
meta-analysis in southern Han Chinese proved the 
association. So, in Chinese, the association of this SNP 
with BP was ethnicity specific (Liu et al., 2014). We 
could not find a significant association of the risk allele 
of rs1799983 with CAD which is consistent with Nassar 
et al. (2001), whereas Nawaz et al. (2015) found a strong 
association of the risk allele with CAD in Pakistani 
people.  Similarly,  the  association  of this polymorphism  
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Table V.- Basic features of the SNPs under study. 
 
Gene CHR SNP Call rate % HWE p-value Cases Controls Total 
       
ACE 17q23,3 rs4341 98 0.593 0.128 0.162 
NOS3 7q36,1 rs1799983 97 0.159 0.158 0.05 
       
CHR, location of the SNP on chromosome; HWE, Hardy Weinberg equilibrium. 
 
Table VI.- Risk allele frequencies and association of the studied SNPs with CAD. 
 
  RAFs CAD OR (CI), p-value 
SNP Alleles Cases (C.I) Controls (C.I) p Additive Recessive Dominant 
        
rs4341 C>G* 0.577 
(0.54-0.61) 
0.525 
(0.48-0.57) 
0.079 1.22 
(0.97-1.53) 0.089 
1.19 
(0.83-1.70) 0.337 
1.47 
(0.99-2.18) 
0.056 
        
rs1799983 G>T* 0.202 
(0.17-0.23) 
0.178 
(0.14-0.21) 
0.312 1.15 
(0.86-1.54) 0.332 
1.15 
(0.53-2.48) 0.74 
1.20 
(0.85-1.71) 
0.30 
        
* is the risk allele; RAF, risk allele frequency; C.I, confidence interval; OR, odds ratio. 
 
Table VII.- Systolic and diastolic blood pressure values by 
genotypes. 
 
SNP Genotype SBP 
(mmHg) 
DBP 
(mmHg) 
    
rs4341 CC 
CG 
GG 
β±Se 
p-value 
124.2±13.2 
135.4±12.9 
144.5±18.3 
10.04±0.8 
<0.001 
83.5±10.7 
87.4±8.9 
88.7±11.4 
2.5±0.6 
<0.001 
    
rs1799983 GG 
GT 
TT 
β±Se 
p-value 
129.8±14.1 
145.6±11 
164±19 
16.4±0.9 
<0.001 
83.8±9.4 
91.5±6.8 
103.9±12 
8.8±0.6 
<0.001 
    
β±Se is effect size with standard error which is increase in 
blood pressure for each additional risk allele held. 
 
with CAD has also been reported in other studies (Hibi et 
al., 1998; Shimasaki et al., 1998; Ben Ali et al., 2015). In 
other two studies the authors could not detect any risk 
allele in heterozygous or homozygous forms in a 
Pakistani and Indian subjects (Nishevitha et al., 2009; 
Taqddus et al., 2014). 
 The difference with respect to CAD association of 
our results with other studies conducted in the same 
region may be due to the genotyping techniques. We  
have genotyped  the  SNPs  with   fully   automated   high  
Table VIII.- Coronary artery disease by combined genotype 
groups. 
 
ACE NOS3 N controls/ 
cases 
OR (95% CI) p- 
value 
     
CC GG 
GT 
TT 
40/51 
14/19 
1/5 
1.00 
1.06 (0.48-2.38) 
3.88 (0.41-190.0) 
- 
0.88 
0.38 
     
CG GG 
GT 
TT 
63/127 
30/56 
5/9 
1(0.95-2.64) 
1.46 (0.80-2.69) 
1.41 (0.39-5.78) 
0.08 
0.22 
0.78 
     
GG GG 
GT 
TT 
48/84 
14/46 
4/7 
1.37 (0.80-2.37) 
2.58 (1.25-5.33) 
1.37 (0.32-6.83) 
0.26 
0.01 
0.88 
     
 
Table IX.- Blood pressure by combined genotype groups. 
 
ACE NOS3 N SBP DBP 
     
CC GG 
GT 
TT 
91 
33 
6 
117.8 (8.1) 
136.1 (8.4) 
154.8 (4.5) 
80.4 (10.4) 
90.3 (7.2) 
93.8 (6.6) 
     
CG GG 
GT 
TT 
190 
86 
14 
130.9 (12.3) 
142.6 (7.9) 
152.0 (11.1) 
85.6 (9.2) 
90.0 (6.5) 
97.4 (7.1) 
     
GG GG 
GT 
TT 
132 
60 
11 
136.4 (14.6) 
155.0 (9.1) 
184.2 (14.2) 
83.7 (8.4) 
94.5 (6.3) 
117.6 (4.4) 
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throughput fluorescence based techniques and randomly 
confirmed the results by direct DNA sequencing; hence 
the results are more reliable. The studied population was 
also in Hardy Weinberg equilibrium collectively as well 
as among cases and controls separately. The allele 
frequencies in our samples were also comparable to the 
allele frequencies of Pakistani Punjabi population from 
Lahore (PJL), a group of 96 subjects from Pakistan 
genotyped in 1000 genomes project phase three. 
 The study has a limitation which is the small sample 
size so modest effects of these SNPs on CAD could not 
be detected. The study power, as calculated, came out to 
be 81.7% with a sample size of 650. In order to have 
100% power, the sample size needed was 1068. It is 
because of a small sample size than required, that we 
couldn’t detect some significant associations evident 
from the nominal p-value for CHD association of the 
selected variants. While NOS3 variant is functional the 
ACE variant is not and may not be in such strong LD with 
the functional variant elsewhere in this gene as in UK 
Caucasians. It is concluded that for both the SNPs, risk 
alleles were associated with BP which may suggest that 
the SNPs are acting through controlling HTN in studied 
Pakistani population. 
 
CONCLUSION 
 
 In conclusion, the SNPs ACE rs4341 and NOS3 
rs1799983 were significantly associated with blood 
pressure in a dose response model in Pakistani subjects 
under study. The SNPs were not independently associated 
with CAD. The effect of SNPs was synergetic on blood 
pressure CAD. 
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